Specifically, following intradermal injection of chicken collagen type II into the base of the tail of KCNN4-/- mice on days 0 and 21, no KCNN4-/- mice developed clinical evidence or histological signs of arthritis, in contrast to wild-type mice. This evidence concerns the gene KCNN4 and arthritic joint disease.